Skip to content

A Prospective Observational Cohort Study to Assess Immune Profiling in Primary IgA Nephropathy

A Prospective Observational Cohort Study to Assess Immune Profiling in Primary IgA Nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005328
Enrollment
Unknown
Registered
2014-10-09
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

Case series:N/A

Sponsors

the First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Renal biopsy diagnosis of IgA nephropathy.between the ages of 18-60 years; (2) Man and woman is allowed; (3) Estimated GFR greater than 60 mL/min/1.73m(2); (4) Given informed consent and long term follow-up; (5) Also, we will study up to 20 healthy adult volunteers and up to 20 kidney disease control(non IgA mesangial proliferation glomerulonephritis, minimal changed disease and primary membrane nephropathy).

Exclusion criteria

Exclusion criteria: (1) Combined with other secondary kidney disease(Henoch-Schonlein purpura nephritis, lupus nephritis, hepatitis b virus associated glomerulonephritis or liver cirrhosis, etc). (2) Combined with systemic disease or autoimmune disease:hepatitis (hepatitis b or c virus), rheumatoid arthritis, Sjgren's syndrome, etc. (3) Taken the glucocorticoids and/or immunosuppresive agents in the last 6 months. (4) Combined with systemic infection:respiratory tract or urinary tract infection within 1 month. (5) Refuse long term follow-up.

Design outcomes

Primary

MeasureTime frame
immune indicators;

Secondary

MeasureTime frame
24-h proteinuria;Glomerular filtration rate(GFR) decreased by 25% o;doubling of serum creatinine;renal replacement treatment;

Contacts

Public ContactLIN HONGLI
linhongli@vip.163.com+86 18098875659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026